146 related articles for article (PubMed ID: 19901127)
41. Carcinoembryonic antigen in patients with breast or colon cancer.
Lee YN
West J Med; 1978 Nov; 129(5):374-80. PubMed ID: 364839
[TBL] [Abstract][Full Text] [Related]
42. [Value of carcinoembryonic antigen (CEA) in the diagnosis and postoperative monitoring of patients with colorectal cancer].
Catania G; Basile F; Cardì F; Azzarello G; Mazzarino C; Campo M; Giovinetto A
Minerva Chir; 1981 May; 36(9):569-80. PubMed ID: 6789243
[No Abstract] [Full Text] [Related]
43. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
44. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
45. [Cost-effectiveness of follow-up studies after curative surgery of colon or rectum carcinoma].
de Ruiter P; Bijnen AB
Ned Tijdschr Geneeskd; 1987 Mar; 131(12):493-6. PubMed ID: 3106836
[No Abstract] [Full Text] [Related]
46. [Increased carcinoembryonic antigen and absence of recurrence in monitoring colorectal cancer].
Forones NM; Tanaka M; Machado D
Arq Gastroenterol; 1998; 35(2):100-3. PubMed ID: 9814374
[TBL] [Abstract][Full Text] [Related]
47. Post-treatment surveillance in a large cohort of patients with colon cancer.
Hu CY; Delclos GL; Chan W; Du XL
Am J Manag Care; 2011 May; 17(5):329-36. PubMed ID: 21718080
[TBL] [Abstract][Full Text] [Related]
48. [Carcino-embryonic antigen as screening protein in the follow-up of patients with surgically-treated gastrointestinal cancer (author's transl)].
Möschl P; Staritz C; Keiler A; Kreuzer W; Fasching W
Wien Klin Wochenschr; 1980 Feb; 92(4):128-30. PubMed ID: 7395229
[TBL] [Abstract][Full Text] [Related]
49. CEA monitoring after primary therapy for colon cancer.
Markman M
J Cancer Res Clin Oncol; 1995; 121(7):385-6. PubMed ID: 7635866
[No Abstract] [Full Text] [Related]
50. Role of prostate specific antigen (PSA) and carcinoembryonic antigen (CEA) in screening for prostate and recurrent colon cancers in the elderly.
Vandenberg TA
Clin Biochem; 1993 Dec; 26(6):429-30. PubMed ID: 7510220
[No Abstract] [Full Text] [Related]
51. Postoperative CEA and Other Non-traditional Risk Factors for Colon Cancer Recurrence: Findings from Swedish Population-Based Data.
Kwaan MR
Ann Surg Oncol; 2020 Apr; 27(4):971-972. PubMed ID: 31853758
[No Abstract] [Full Text] [Related]
52. Aneurismal type of colorectal cancer: imaging characteristics of gastrointestinal endoscopy, computed tomography and magnetic resonance imaging.
Mizuguchi M; Irie H; Nanazono T; Kamochi N; Egashira Y; Nishihara M; Shimoda R; Tsunada S; Iwakiri R; Fujimoto K; Kudo S
Hepatogastroenterology; 2011; 58(106):395-9. PubMed ID: 21661402
[TBL] [Abstract][Full Text] [Related]
53. [The value of CT examination for diagnosis of postoperative colonic cancer recurrences using bi-contrast and mono-contrast enema and air].
Krupski W; Złomaniec J; Bryc S; Złomaniec G
Ann Univ Mariae Curie Sklodowska Med; 1997; 52():129-39. PubMed ID: 10023168
[TBL] [Abstract][Full Text] [Related]
54. Carcinoembryonic antigen monitoring to detect recurrence of colorectal cancer: how should we interpret the test results?
Shinkins B; Nicholson BD; James TJ; Primrose JN; Mant D
Clin Chem; 2014 Dec; 60(12):1572-4. PubMed ID: 25161147
[No Abstract] [Full Text] [Related]
55. [After care following surgery for colon cancer. 1. Objectives and organization of after care].
Schlag P
Aktuelle Probl Chir Orthop; 1979; (10):50-5. PubMed ID: 32793
[No Abstract] [Full Text] [Related]
56. ASO Author Reflections: Emerging Risk Factors in Colon Cancer-End of the Line for Clinomics?
Osterman E; Glimelius B
Ann Surg Oncol; 2020 Apr; 27(4):1046-1047. PubMed ID: 31884560
[No Abstract] [Full Text] [Related]
57. Development and validation of a model to predict outcomes of colon cancer surveillance.
Rose J; Homa L; Kong CY; Cooper GS; Kattan MW; Ermlich BO; Meyers JP; Primrose JN; Pugh SA; Shinkins B; Kim U; Meropol NJ
Cancer Causes Control; 2019 Jul; 30(7):767-778. PubMed ID: 31129907
[TBL] [Abstract][Full Text] [Related]
58. CEA for monitoring colon cancer.
Chu DZ; Ellenhorn JD; Paz IB; Wagman LD; Williams WL
JAMA; 1994 Feb; 271(5):345-6; author reply 346-7. PubMed ID: 8283579
[No Abstract] [Full Text] [Related]
59. Elevation of Pretreatment Carcinoembryonic Antigen Level as a Prognostic Factor for Colon Cancer: Incorporating a C Stage in the AJCC TNM Classification.
Amri R; Berger DL
JAMA Surg; 2015 Aug; 150(8):755-6. PubMed ID: 26083189
[No Abstract] [Full Text] [Related]
60. ASO Author Reflections: Assessing the Diagnostic Accuracy of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen to Detect Recurrent Colon Cancer.
Dawood ZS; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Jan; 30(1):275-276. PubMed ID: 36310308
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
